collection
MENU ▼
Read by QxMD icon Read
search

Rare site DVT

shared collection
6 papers 25 to 100 followers
https://www.readbyqxmd.com/read/22040061/long-term-follow-up-of-patients-with-portal-vein-thrombosis-and-myeloproliferative-neoplasms
#1
J Hoekstra, E L Bresser, J H Smalberg, M C W Spaander, F W G Leebeek, H L A Janssen
BACKGROUND: Myeloproliferative neoplasms (MPNs) are frequently identified as an underlying cause in patients with non-cirrhotic portal vein thrombosis (PVT). The aim of this study was to describe the long-term outcome of patients with PVT and MPN. METHODS: A cohort study was performed including all adult patients referred to our hospital between 1980 and 2008 with non-cirrhotic, non-malignant PVT and confirmed MPN. RESULTS: A total of 44 patients (70% female) were included, with a median age at PVT-diagnosis of 48 years (range 18-79)...
November 2011: Journal of Thrombosis and Haemostasis: JTH
https://www.readbyqxmd.com/read/26333846/splanchnic-vein-thrombosis-and-myeloproliferative-neoplasms-molecular-driven-diagnosis-and-long-term-treatment
#2
REVIEW
Valerio De Stefano, Xingshun Qi, Silvia Betti, Elena Rossi
Splanchnic vein thrombosis (SVT) encompasses Budd-Chiari syndrome (BCS), extrahepatic portal vein obstruction (EHPVO), and mesenteric vein thrombosis. Philadelphia-negative myeloproliferative neoplasms (MPNS) are the leading systemic cause of non-cirrhotic and non-malignant SVT and are diagnosed in 40% of BCS patients and one-third of EHPVO patients. In SVT patients the molecular marker JAK2 V617F is detectable up to 87% of those with overt MPN and up to 26% of those without. In the latter, other MPN molecular markers, such as mutations in JAK2 exon 12, CALR and MPL genes, are extremely rare...
January 2016: Thrombosis and Haemostasis
https://www.readbyqxmd.com/read/23043069/myeloproliferative-neoplasms-in-budd-chiari-syndrome-and-portal-vein-thrombosis-a-meta-analysis
#3
REVIEW
Jasper H Smalberg, Lidia R Arends, Dominique C Valla, Jean-Jacques Kiladjian, Harry L A Janssen, Frank W G Leebeek
Myeloproliferative neoplasms (MPNs) are the most common cause of Budd-Chiari syndrome (BCS) and nonmalignant, noncirrhotic portal vein thrombosis (PVT). In this meta-analysis, we determined the prevalence of MPNs and their subtypes as well as JAK2V617F and its diagnostic role in these uncommon disorders. MEDLINE and EMBASE databases were searched. Prevalence of MPNs, JAK2V617F, and MPN subtypes were calculated using a random-effects model. A total of 1062 BCS and 855 PVT patients were included. In BCS, mean prevalence of MPNs and JAK2V617F was 40...
December 13, 2012: Blood
https://www.readbyqxmd.com/read/23073861/cerebral-sinus-venous-thrombosis
#4
REVIEW
Ida Martinelli, Serena Maria Passamonti, Elena Rossi, Valerio De Stefano
Cerebral sinus-venous thrombosis (CSVT) is a rare life-threatening disease with an estimated annual incidence of 3-4 cases per million in adults and 7 cases per million in neonates. Brain tumors, cerebral infections and traumas are local risk factors for CSVT, but the commonest encountered risk factors are oral contraceptive use, pregnancy and puerperium that make the disease predominant in female sex. In 15-20 % of patients, the disease remains unprovoked, i.e., occurring in the absence of predisposing factors...
October 2012: Internal and Emergency Medicine
https://www.readbyqxmd.com/read/22869858/management-of-deep-vein-thrombosis-of-the-upper-extremity
#5
REVIEW
Rolf P Engelberger, Nils Kucher
No abstract text is available yet for this article.
August 7, 2012: Circulation
https://www.readbyqxmd.com/read/21293023/diagnosis-and-management-of-cerebral-venous-thrombosis-a-statement-for-healthcare-professionals-from-the-american-heart-association-american-stroke-association
#6
REVIEW
Gustavo Saposnik, Fernando Barinagarrementeria, Robert D Brown, Cheryl D Bushnell, Brett Cucchiara, Mary Cushman, Gabrielle deVeber, Jose M Ferro, Fong Y Tsai
BACKGROUND: The purpose of this statement is to provide an overview of cerebral venous sinus thrombosis and to provide recommendations for its diagnosis, management, and treatment. The intended audience is physicians and other healthcare providers who are responsible for the diagnosis and management of patients with cerebral venous sinus thrombosis. METHODS AND RESULTS: Members of the panel were appointed by the American Heart Association Stroke Council's Scientific Statement Oversight Committee and represent different areas of expertise...
April 2011: Stroke; a Journal of Cerebral Circulation
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"